... $2.68 on average, according to estimates compiled by Bloomberg. Revenue increased 39% to $870 million, the Tarrytown, N.Y.-based company said Thursday in a statement. Analysts had predicted $824 million. U.S. sales of Eylea, Regeneron's top drug , ...
http://ift.tt/1F1n5aY
No comments:
Post a Comment